Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


Articles published in Oncogene

Retrieve available abstracts of 29 articles:
HTML format
Text format



Single Articles


    July 2017
  1. FAN LC, Shiau CW, Tai WT, Hung MH, et al
    SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.
    Oncogene. 2017 Jul 17. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    May 2017
  2. CHI HC, Chen SL, Lin SL, Tsai CY, et al
    Thyroid hormone protects hepatocytes from HBx-induced carcinogenesis by enhancing mitochondrial turnover.
    Oncogene. 2017 May 15. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  3. XIN B, Yamamoto M, Fujii K, Ooshio T, et al
    Critical role of Myc activation in mouse hepatocarcinogenesis induced by the activation of AKT and RAS pathways.
    Oncogene. 2017 May 8. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    March 2017
  4. CHEN H, Cai W, Chu ES, Tang J, et al
    Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice.
    Oncogene. 2017 Mar 27. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  5. HU X, Zhao Y, Wei L, Zhu B, et al
    CCDC178 promotes hepatocellular carcinoma metastasis through modulation of anoikis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  6. ZHOU M, Mok MT, Sun H, Chan AW, et al
    The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis.
    Oncogene. 2017 Mar 20. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


  7. DENG L, Tang J, Yang H, Cheng C, et al
    MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway.
    Oncogene. 2017 Mar 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  8. ZHANG HR, Wang XD, Yang X, Chen D, et al
    An FGFR inhibitor converts the tumor promoting effect of TGF-beta by the induction of fibroblast-associated genes of hepatoma cells.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    February 2017
  9. SUN H, Peng Z, Tang H, Xie D, et al
    Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-beta signaling in and promote progression of hepatocellular carcinoma.
    Oncogene. 2017 Feb 13. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  10. LIN Y, Yang X, Liu W, Li B, et al
    Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.
    Oncogene. 2017 Feb 6. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2017
  11. HERMANNS C, Hampl V, Holzer K, Aigner A, et al
    The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
    Oncogene. 2017 Jan 23. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    November 2016
  12. MENG Z, Ma X, Du J, Wang X, et al
    CAMK2gamma antagonizes mTORC1 activation during hepatocarcinogenesis.
    Oncogene. 2016 Nov 7. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    October 2016
  13. FAN H, Cui Z, Zhang H, Mani SK, et al
    DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.
    Oncogene. 2016 Oct 31. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  14. LIAO PH, Hsu HH, Chen TS, Chen MC, et al
    Phosphorylation of cofilin-1 by ERK confers HDAC inhibitor resistance in hepatocellular carcinoma cells via decreased ROS-mediated mitochondria injury.
    Oncogene. 2016 Oct 17. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    September 2016
  15. DENG Y, Cheng J, Fu B, Liu W, et al
    Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells.
    Oncogene. 2016 Sep 5. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    August 2016
  16. CAO C, Zhang T, Zhang D, Xie L, et al
    The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma.
    Oncogene. 2016 Aug 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  17. ZHOU X, Zhang CZ, Lu SX, Chen GG, et al
    miR-625 suppresses tumour migration and invasion by targeting IGF2BP1 in hepatocellular carcinoma.
    Oncogene. 2016 Aug 8. doi: 10.1038/onc.2016.
    PubMed     Text format    


  18. LIN KT, Shann YJ, Chau GY, Hsu CN, et al
    Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing.
    Oncogene. 2016 Aug 1. doi: 10.1038/onc.2016.
    PubMed     Text format    


    May 2016
  19. SHEN J, Tsoi H, Liang Q, Chu ES, et al
    Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma.
    Oncogene. 2016 May 2. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    April 2016
  20. LIU F, Yuan JH, Huang JF, Yang F, et al
    Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
    Oncogene. 2016 Apr 11. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  21. WU J, Lu M, Li Y, Shang YK, et al
    Regulation of a TGF-beta1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  22. NA TY, Ka NL, Rhee H, Kyeong D, et al
    Interaction of hepatitis B virus X protein with PARP1 results in inhibition of DNA repair in hepatocellular carcinoma.
    Oncogene. 2016 Apr 4. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    March 2016
  23. MORIOKA S, Sai K, Omori E, Ikeda Y, et al
    TAK1 regulates hepatic lipid homeostasis through SREBP.
    Oncogene. 2016 Mar 14. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    February 2016
  24. HUNG MH, Chen YL, Chu PY, Shih CT, et al
    Upregulation of the oncoprotein SET determines poor clinical outcomes in hepatocellular carcinoma and shows therapeutic potential.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


  25. AHRONIAN LG, Zhu LJ, Chen YW, Chu HC, et al
    A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
    Oncogene. 2016 Feb 15. doi: 10.1038/onc.2016.
    PubMed     Text format     Abstract available


    January 2016
  26. WANG W, Liao P, Shen M, Chen T, et al
    SCP1 regulates c-Myc stability and functions through dephosphorylating c-Myc Ser62.
    Oncogene. 2016;35:491-500.
    PubMed     Text format     Abstract available


  27. URTASUN R, Elizalde M, Azkona M, Latasa MU, et al
    Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression.
    Oncogene. 2016 Jan 25. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    July 2015
  28. ZHU G, Li X, Guo B, Ke Q, et al
    PAK5-mediated E47 phosphorylation promotes epithelial-mesenchymal transition and metastasis of colon cancer.
    Oncogene. 2015 Jul 27. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


    March 2015
  29. PARISI T, Bronson RT, Lees JA
    Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.
    Oncogene. 2015 Mar 9. doi: 10.1038/onc.2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: